This inventor holds 1 USPTO granted patent. Top assignee: The Boots Company Plc. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Teruo Mukai: Innovator in Cerebral Function Improvement
Introduction
Teruo Mukai is a notable inventor based in Joyo, Japan. He has made significant contributions to the field of pharmacology, particularly in the development of treatments for cerebral function disorders. His innovative approach has led to advancements that can potentially improve the quality of life for individuals suffering from various neurological conditions.
Latest Patents
Mukai holds a patent for the use of N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine. This compound, or a pharmacologically acceptable acid addition salt thereof, is designed for the manufacture of a cerebral function improver. It is particularly useful in treating cerebral function disorders such as amnestic syndrome, senile dementia, and Parkinson's disease. The invention is notable for its ability to intensively activate the central nervous system, especially dopamine neurons, and increase spontaneous movement in both humans and animals. He has 1 patent to his name.
Career Highlights
Mukai is associated with The Boots Company Plc, where he has been able to apply his research and innovations in a practical setting. His work has been instrumental in advancing the understanding and treatment of cerebral function disorders.
Collaborations
Mukai has collaborated with notable colleagues such as Kiyoharu Ukai and Chiharu Masuda. Their combined expertise has contributed to the success of their projects and the development of effective treatments.
Conclusion
Teruo Mukai's contributions to the field of cerebral function improvement highlight the importance of innovation in medical science. His work not only showcases his inventive spirit but also offers hope for those affected by neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile